Abstract
Ependymomas are relatively rare gliomas arising from the differentiated ependymal cell layer lining the ventricular system and central canal of the spinal cord. Intracranial ependymomas account for approximately 9% of all brain tumors in the population under 20 years of age, and are the third most common primary brain tumor in children (following astrocytomas and primitive neuroectodermal tumors). According to SEER (Surveillance, Epidemiology and End Results) data from 1975 until 1998, the annual incidence of ependymoma is 2.6 per million for the 0 to 14 age group, and 2.2 per million for the 0 to 20 age group (Ries et al. 1999). Population-based measurements of the incidence of spinal cord ependymoma in children are available from the Connecticut Tumor Registry. Between 1935 and 1973, 5 spinal cord ependymomas and 44 intracranial ependymomas were identified in the Connecticut population under 20 years of age; suggesting that spinal cord ependymoma represents approximately 10% of all ependymal tumors in children and young adults (Dohrmann et al. 1976). Another large institutional series confirmed that spinal cord ependymomas are rare in children under 10 years of age, accounting for less than 1% of all spinal tumors. After age 10, the incidence of spinal cord ependymoma increases, and it represents the majority of intramedullary tumors in patients older than 20 years (Constantini et al. 1997).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aggarwal R, Yeung D, Kumar P et al (1997) Efficacy and feasibility of stereotactic radiosurgery in the primary management of unfavorable pediatric ependymoma. Radiother Oncol 43:269–273
Awaad Y, Allen J, Miller D et al (1996) Deferring adjuvant therapy for totally resected intracranial ependymoma. Pediatr Neurol 14: 216–219
Bergsagel D, Finegold M, Butel J et al (1992) DNA sequences similar to those of Simian virus 4o in ependymomas and choroid plexus tumors of childhood. N Engl J Med 326: 988–993
Birch B, Johnson J, Parsa A et al (1996) Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas. Neurosurgery 39: 135–140
Carbone M, Rizzo P, Pass H (1997) Simian virus 4o, poliovaccines and human tumors: a review of recent developments. Oncogene 15: 1877–1888
Cervoni L, Celli P, Fortuna A et al (1994) Recurrence of spinal ependymoma. Risk factors and long-term survival. Spine 19: 2838–2841
Ciraldo A, Platt M, Agamanolis D et al (1986) Sacrococcygeal myxopapillary ependymomas and ependymal rests in infants and children. J Pediatr Surg 21:49–52
Constantini S, Allen J, Epstein F (1997) Pediatric and adult primary spinal cord tumors. In: Black P, Loeffler J (eds) Cancer of the nervous system. Blackwell Science, Cambridge, pp 638–639
Coulon R, Till K (1977) Intracranial ependymomas in children. Child’s Brain 3x54–168
Debiec-Rychter M, Hagemeijer A, Sciot R (woo) Cytogenetic analysis in three cerebral subependymomas: further evidence for a hamartomatous nature? Cancer Genet Cytogenet 122: 63–64
Dohrmann G, Farwell J, Flannery J (1976) Ependymomas and ependymoblastomas in children. J Neurosurg 45: 273–281
Duffner P, Horowitz M, Krischer J et al (1993) Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328: 1725–1731
Furie D, Provenzale J (1995) Supratentorial ependymomas and subependymomas: CT and MR appearance. J Comput Assist Tomogr 19: 518–526
Garrett P, Simpson W (1983) Ependymomas: results of radia- tion treatment. Int J Radiat Oncol Biol Phys 9: 1121–1124
Gerston K, Suprun H, Cohen H et al (1985) Presacral myxopapillary ependymoma presenting as an abdominal mass in a child. J Pediatr Surg 20: 276–278
Geyer R, Zeltzer P, Boyett J et al (1994) Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in I day: a report from the Childrens Cancer Group. J Clin Oncol 12x607–1615
Gold E, Leviton A, Lopez R et al (1994) The role of family histo- ry in risk of childhood brain tumors. Cancer 73x302–1311
Goldwein J, Glauser T, Packer R et al (1990) Recurrent intracranial ependymomas in children. Cancer 66: 557–563
Goldwein J, Corn B, Finlay J et al (1991) Is craniospinal irradiation required to cure children with malignant (anaplastic) intracranial ependymomas? Cancer 67: 2766–2771
Good C, Wade A, Hayward R et al (2001) Surveillance neuroimaging in childhood intracranial ependymoma: how effective, how often, and for how long? J Neurosurg 94: 27–32
Gornet M, Buckner J, Marks R et al (1999) Chemotherapy for advanced CNS ependymoma. J Neurooncol 45: 61–67
Grill J, Kalifa C, Doz F et al (1996) A high-dose busulfanthiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. Pediatr Neurosurg 25: 7–12
Grill J, Renaux V, Bulteau C et al (1999) Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol Biol Phys 45: 137–145
Grill J, Le Deley M, Gambarelli D et al (2001) Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol 19: 1288–1296
Hamilton R, Pollack I (1997) The molecular biology of ependymomas. Brain Pathol 7: 807–822
Hemminki K, Li X, Vaittinen Pet al (woo) Cancers in the first-degree relatives of children with brain tumours. Br J Cancer 83: 407–411
Hirose Y, Aldape K, Bollen A et al (2001) Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. Am J Pathol 158: 1137–1143
Hodgson D, Goumnerova L, Loeffler J et al (2001) Radiosurgery in the management of pediatric brain tumors. Int J Radiat Oncol Biol Phys 50: 929–935
Horn B, Heidman R, Geyer R et al (1999) A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors. J Pediatr Hematol Oncol
-211
Hukin J, Epstein F, Fefton D, Allen J (1998) Treatment of intracranial ependymoma by surgery alone. Pediatr Neurosurg 29: 40–45
Hulsebos T, Oskam N, Bijleveld E et al (1999) Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter-22q11.2. Br J Cancer 81: 1150–1154
Ilgren E, Stiller C, Hughes J et al (1984) Ependymomas: a clinical and pathologic study. I. Biologic features. Clin Neuropathol 3: 113–121
Jinnouchi T, Shibata S, Fukushima M et al (1989) Ultrastructure of blood capillary permeability in human brain tumors, part 7. Ependymoma. J Clin Electron Micros 22: 57–63
Kirschstein R, Gerger P (1962) Ependymomas produced after intracerebral inoculation of SV4o into newborn hamsters. Nature 195:299–300
Kleihues P, Cayenne WK (2000) Pathology and genetics of the nervous system. IARC Press, Lyon
Lamszus K, Lachenmayer L, Heinemann U (2001) Molecular genetic alterations on chromosomes n and 22 in ependymomas. Int J Cancer 91: 803–808
Lee M, Rezai A, Freed D et al (1996) Intramedullary spinal cord tumors in neurofibromatosis. Neurosurgery 38: 32–37
Martini F, Iaccheri L, Lazzarini L et al (1996) SV4o early region and large T antigen in human brain tumors, peripheral blood cells and sperm fluids from healthy individuals. Cancer Res 56: 4820–4825
Mason W, Grovas A, Halpern S et al (1998a) Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. J Clin Oncol 16: 210–221
Mason W, Goldman S, Yates A et al (1998b) Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma. J Neurooncol 37:135–143
Merchant T, Thompson S, Williams T et al (2000) Preliminary results from a phase II trial of conformal radiation therapy for localized pediatric brain tumors. 2000 annual meeting of the American Society of Therapeutic Radiology and Oncology. Boston, MA, 22–26 Oct. Int J Radiol Oncol Biol Phys 48380–181
Mork S, Loken A (1977) Ependymoma: a follow-up study of 101 cases. Cancer 40: 907–915
Nadkarni T, Rekate H (1999) Pediatric intramedullary spinal cord tumors. Child’s Nery Syst 15: 17–28
Nazar G, Hoffman H, Becker L et al (1990) Infratentorial ependymomas in childhood: prognostic factors and treatment. J Neurosurg 72: 408–417
Newton H, Henson J, Walker R (1992) Extraneural metastases in ependymoma. J Neurooncol 14:135–142
Osterdock R, Sanford R, Merchant T (2000) Pediatric ependymoma (40 in 36 months). 2000 AANS/CNS Section on Pediatric Neurological Surgery Annual Meeting. Coronado, California, 6–9 Dec 2000
Perilongo G, Massimino M, Sotti G et al (1997) Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-Oncology Group. Med Pediatr Oncol 29:79–85
Prayson R, Suh J (1999) Subependymomas: clinicopathologic study of 14 tumors, including comparative MIB-1 immunohistochemical analysis with other ependymal neoplasms. Arch Pathol Lab Med 123: 306–309
Reardon D, Entrekin R, Sublett J et al (1999) Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma. Genes Chromosom Cancer 24:230–237
Reyes-Mugica M, Chou PM, Myint MM et al (1994) Ependymomas in children: histologic and DNA-flow cytometric study. Pediatr Pathol 14: 453–466
Ries L, Smith M, Gurney J et al (eds) (1999) Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995 National Cancer Institute, SEER Program. NIH Publ no 99–4649. Bethesda, MD
Robertson P, Zeltzer P, Boyett J et al (1998) Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children’s Cancer Group. J Neurosurg 88: 695–703
Ross G, Rubinstein L (1989) Lack of histological correlation of malignant ependymomas with postoperative survival. J Neurosurg 70: 31–36
Rousseau P, Habrand J, Serrazin D et al (1994) Treatment of intracranial ependymomas of children: review of a 15-year experience. Int J Radiat Oncol Biol Phys 28: 381–386
Salazar O, Rubin P, Bassano D et al (1975) Improved survival of patients with intracranial ependymoma by irradiation therapy. Dose escalation and field extension. Cancer 35:1563–1573
Sara A, Bruner J, Mackay B (1994) Ultrastructure of ependymoma. Ultrastruct Pathol 18: 33–42
Scheil S, Bruderlein S, Eicker M et al (2001) Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization. Brain Pathol 11333–143
Schiffer D, Chio A, Giordana M et al (1991) Histologic prognos- tic factors in ependymoma. Child’s Nery Syst 7: 177–182
Shaw E, Evans R, Scheithauer B et al (1987) Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients. Int J Radiat Oncol Biol Phys 13:1457–1462
Slasky B, Bydder G, Niendrof H et al (1987) MR imaging with gadolinium-DTPA in the differentiation of tumor, syrinx and cyst of the spinal cord. J Compt Tomogr 11: 845–850
Strickler H, Rosenberg P, Devesa S et al (1998) Contamination of poliovirus vaccines with Simian virus 40 (1955–1963) and subsequent cancer rates. JAMA 279: 292–295
Timmermann B, Kortmann R, Kuhl J et al (2000) Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT 88/89 and HIT 91. Int J Radiat Oncol Biol Phys 46: 287–295
Tortori-Donati P, Fondelli M, Cama A et al (1995) Ependymomas of the posterior cranial fossa: CT and MRI findings. Neuroradiology 37: 238–243
Vanuytsel LJ, Brada M (1991) The role of prophylactic spinal irradiation in localized intracranial ependymoma. Int J. Radiat Oncol Biol Phys 21: 825–830
Wager M, Lapierre F, Blanc J et al (2000) Cauda equina tumors: a French multicenter retrospective review of 231 adult cases and review of the literature. Neurosurg Rev 23: 119–129
Waldron J, Laperriere N, Jaakkimainen L et al (1993) Spinal cord ependymomas: a retrospective analysis of 59 cases. Int J Radiat Oncol Biol Phys 27: 223–229
Walker R, Allen J (1988) Cisplatin in the treatment of recurrent primary brain tumors. J Clin Oncol 6: 62–66
Ward S, Harding B, Wilkins P et al (2001) Gain 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in pediatric ependymoma. Genes Chromosom Cancer 32: 59–66
White L, Kellie S, Gray E et al (1998) Postoperative chemotherapy in children less than 4 years of age with malignant brain tumors: promising initial response to a VETOPECbased regimen. J Pediatr Hematol Oncol 20x25–130
Whitaker S, Bessel E, Ashley Set al (1991) Postoperative radiotherapy in the management of spinal cord ependymoma. J Neurosurg 74: 720–728
Woesler B, Moskopp D, Kuchelmeister K et al (1998) Intracranial metastasis of a spinal myxopapillary ependymoma: Case report. Neurosurg Rev 21: 62–65
Zhen H, Zhang X, Bu X et al (1999) Expression of the Simian virus 40 large tumor antigen (Tag) and formation of Tag-p53 and Tag-pRb complexes in human brain tumors. Cancer 86: 2124–2132
Zheng P, Pang J, Hui A et al (2000) Comparative genomic hybridization detects losses of chromosomes 22 and 16 as the most common recurrent genetic alterations in primary ependymomas. Cancer Genet Cytogenet 122: 18–15
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Horn, B.N., Smyth, M. (2004). Ependymoma. In: Gupta, N., Banerjee, A., Haas-Kogan, D. (eds) Pediatric CNS Tumors. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-09227-9_5
Download citation
DOI: https://doi.org/10.1007/978-3-662-09227-9_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-05554-6
Online ISBN: 978-3-662-09227-9
eBook Packages: Springer Book Archive